Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

medicines access

Novartis reaffirms commitment to UK respiratory research site

Will slim down and redevelop Horsham facility

- PMLiVE

Novartis eye drug Jetrea effective in phase III

Pharma company and its partner ThromboGenics report positive trial data

- PMLiVE

Astellas Pharma Europe appoint new senior director, market access

Dr Susan Wood was previously senior brand director of the company’s pain management franchise 

AstraZeneca and BGT shelve experimental sepsis drug

Decision follows CytoFab’s poor mid-stage clinical trial results

Novartis day

Novartis signs cancer immunotherapy deal with Penn

R&D alliance with the University of Pennsylvania will focus on novel T-cell immunotherapies

- PMLiVE

Interview: Deepak Khanna, ABPI

Collaboration, communication and an appropriate drug pricing scheme are key says ABPI president

- PMLiVE

Pillars of success in market access

The key to true market access success begins with corporate ownership…

- PMLiVE

Proving value in uncertain times

Industry needs to be perceived as a contributor to healthcare solutions not just a cost

- PMLiVE

How to win through integrating market access

Embedding and integrating market access strategies company-wide is key

- PMLiVE

The role of systematic review in market access

Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world? 

UK reaffirms NHS access to NICE-approved drugs

Health Secretary makes pledge on same day Future Forum recommendations on NHS reform accepted

- PMLiVE

Interview: Joseph Jimenez, Novartis

Novartis' CEO tells Linda Banks how investing in innovation and parallel development is helping to keep the company at the forefront

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links